Clinical Trial Update: A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia

View source ↗

Summary

A clinical trial update describing monitoring of adverse events for the QDENGA dengue vaccine in participants in Malaysia, sponsored by Takeda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Qdenga (TAK-003)

Snippet

Sponsor: Takeda | Conditions: Dengue Fever | Status: RECRUITING